Package Leaflet: Information for the User
Esomeprazole cinfa 20 mg gastro-resistant tablets EFG
Esomeprazole sodium
Read this leaflet carefully before you start to take this medicine because it contains important information for you.
Esomeprazol cinfa contains a medicine called esomeprazol that belongs to a group of medicines called “proton pump inhibitors”. These work by reducing the amount of acid produced by the stomach.
Esomeprazol is used for the treatment of the following disorders:
Adults
Adolescents aged 12 years and above
Do not take esomeprazol cinfa
If you are in any of these situations, do not take esomeprazol. If you are unsure, consult your doctor or pharmacist before taking esomeprazol.
Warnings and precautions
Consult your doctor or pharmacist before starting to take esomeprazol cinfa
Esomeprazol may mask the symptoms of other diseases.Therefore, if you notice any of the following events before taking or while taking esomeprazol, contact your doctor immediately:
If you have been prescribed esomeprazol only when you notice some symptoms, you should contact your doctor if the symptoms of your disease persist or change.
Severe skin reactions that include Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in relation to esomeprazol treatment. Stop taking esomeprazol and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Taking a proton pump inhibitor like esomeprazol, especially for a period of more than one year, may slightly increase the risk of fractures of the hip, wrist, or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt esomeprazol treatment. Remember to mention any other symptoms you may notice, such as joint pain.
Children under 12 years
Esomeprazol tablets are not recommended for children under 12 years.
Taking esomeprazol cinfa with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
This includes medications purchased without a prescription. This is because esomeprazol may affect the way some medications work and some medications may influence the effect of esomeprazol.
Do not take esomeprazol if you are taking
Inform your doctor if you are using any of the following medications:
If your doctor has prescribed antibiotics amoxicilina and claritromicina in addition to esomeprazol to treat ulcers caused by Helicobacter pylori, it is very important to inform your doctor if you are taking any other medication.
Taking esomeprazol cinfa with food and drinks
You can take the tablets with food or on an empty stomach.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Your doctor will decide if you can take esomeprazol during this period.
The passage of esomeprazol into breast milk is unknown. Therefore, do not take esomeprazol during breastfeeding.
Driving and operating machinery
Esomeprazol is unlikely to affect your ability to drive or use tools or machines. However, rare or very rare side effects such as dizziness or blurred vision (see section 4) may occur. Do not drive or use machines if you notice any of these effects.
Esomeprazol cinfa contains sodium.This medication contains less than 23 mg of sodium (1 mmol) per tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
How much to take
Use in adults aged 18 years and older
For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):
Once your esophagus has healed, the recommended dose is one esomeprazole 20 mg tablet per day.
For the treatment of ulcers caused by Helicobacter pylori infection and to prevent their recurrence:
For the treatment of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs):
For the prevention of gastric ulcers if you are taking NSAIDs:
For the treatment of excessive stomach acid caused by a tumor in the pancreas (Zollinger-Ellison syndrome):
Use in adolescents aged 12 years and older
For the treatment of heartburn caused by gastroesophageal reflux disease (GERD):
For the treatment of ulcers caused by Helicobacter pylori infection and to prevent their recurrence:
How to take this medication
What to do if you have difficulty swallowing
Use in children under 12 years of age
Esomeprazole coated granules are not recommended for children under 12 years of age.
Older adults
No dose adjustment is necessary in older adults.
If you take more esomeprazole than you should
If you take more esomeprazole than your doctor has told you to, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take esomeprazole
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following serious side effects, stop taking esomeprazole and contact a doctor immediately:
These side effects are rare and may affect up to 1 in 1,000 people.
Other side effects include:
Frequent (may affect up to 1 in 10 people)
Occasional (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
In very rare cases, esomeprazole may affect white blood cells, causing immunodeficiency. If you have an infection with symptoms such as high fever with severe worsening of the general condition or fever with symptoms of a local infection such as neck pain, throat pain, mouth pain, or difficulty urinating, you should consult your doctor as soon as possible to rule out a decrease in white blood cells (agranulocytosis) through a blood test. It is essential to inform your doctor about your medication in this case.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label, the box, or blister pack after CAD. The expiration date is the last day of the month indicated.
Blister packs
Do not store at a temperature above 30°C.
Store in the original packaging to protect it from moisture.
Bottles:
Do not store at a temperature above 30°C.
Shelf life after the first opening of the bottle: 100 days
Keep the bottle perfectly closed to protect it from moisture.
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of esomeprazole cinfa
Appearance of the product and contents of the package
Esomeprazole cinfa 20 mg are oval-shaped, gastro-resistant tablets of blue color.
They are presented in blister packs and bottles of 14, 28, 56, and 100 (clinical pack) tablets.
Only some package sizes may be commercially available.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta.
31620 Huarte (Navarra) - España
Responsible for manufacturing
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta.
31620 Huarte (Navarra) - España
or
TOWA PHARMACEUTICAL EUROPE S.L.
C/ San Martí, 75-97
Martorelles, 08107 Barcelona
España
Last review date of this leaflet: January 2025
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/75071/P_75071.html
QR code to: https://cima.aemps.es/cima/dochtml/p/75071/P_75071.html
This information is intended only for healthcare professionals:
Administration through gastric tube
1. Insert the tablet into a suitable syringe and fill the syringe with approximately 25 ml of water and approximately 5 ml of air. For some tubes, a dispersion in 50 ml of water is required to prevent the pellets from blocking the tube.
2. Immediately agitate the syringe for approximately 2 minutes to disperse the tablet.
3. Hold the syringe with the tip pointing upwards and check that the tip has not become blocked.
4. Connect the syringe to the tube while maintaining the previous position.
5. Agitate the syringe and place it with the tip pointing downwards. Immediately inject 5-10 ml into the tube.
Invert the syringe after injection and agitate (the syringe must be kept with the tip pointing upwards to prevent the tip from becoming blocked).
6. Place the syringe with the tip pointing downwards and immediately inject another 5-10 ml into the tube. Repeat this procedure until the syringe is empty.
7. Fill the syringe with 25 ml of water and 5 ml of air and repeat step 5 if necessary to draw any remaining sediment from the syringe. For some tubes, 50 ml of water is required.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.